The following information is summarized from the records of city, county and state police, fire and hospital agencies.

The cells targeted the cancer and eradicated it. Thirteen years later, Whitehead is still cancer-free. Since then, however, ...

A study of more than 100 patients found that immunotherapy can cure a rare type of cancer in various tumor sites without ...

According to the results of a new study in the New England Journal of Medicine, 92% of patients who took this drug were cancer-free after two years.

People who take Wegovy appear to be at greater risk for hair loss, according to an early study that hasn't yet been ...

The results from an ambitious cancer study are giving hope that immunotherapy drugs alone can treat some ... a gastrointestinal medical oncologist at Memorial Sloan Kettering Cancer Center in ...

Sloan cautions that only two things should ever be flushed down a toilet: Human waste and toilet paper. Toilet paper is ...

A Davie mom fighting a rare and rapidly spreading cancer is enrolled in a pioneering clinical trial at Memorial Cancer ...

The son of former Blazers and Kings coach Rick Adelman, the Nuggets' interim head coach has spent a lifetime preparing for ...

The first drug for a rare and difficult-to-treat type of ovarian cancer ... in the United States by gynecologic medical oncologist Rachel Grisham, MD, of Memorial Sloan Kettering Cancer Center (MSK).

82 out of 103 participants responded so well to the drug that they no longer needed an operation. While the results are promising, the study was conducted at a single hospital -- Memorial Sloan ...

A new clinical trial shows the immunotherapy drug dostarlimab could eliminate the need for surgery ... Center for Young Onset Colorectal and Gastrointestinal Cancer at Memorial Sloan Kettering Cancer ...